$MYL Recent News U.S. stocks: Dow closes above
Post# of 94122
![Avatar](/images/ProfileImages/410421673_9050_Stock_Tracker.jpg)
U.S. stocks: Dow closes above 17,000 4:03 p.m. July 14, 2014 - Anora Mahmudova
Tesla, Citigroup gain; GoPro tumbles 3:41 p.m. July 14, 2014 - Angela Johnson
Stocks end with solid gains, but Dow can't hang on for record close: live blog recap 3:31 p.m. July 14, 2014 - blogs.marketwatch.com
Mylan shares rise 4.6% in premarket 7:59 a.m. July 14, 2014 - Tomi Kilgore
Abbott Labs to sell part of generics business for $5.3 billion 7:35 a.m. July 14, 2014 - Anna Prior
Tesla sued in China; Groupon gets upgrade 2:21 p.m. July 8, 2014 - Sue Chang
Apple falls on Beats news; Tesla recovers from selloff 3:57 p.m. May 9, 2014 - Sue Chang
Plug Power tanks on fuel-cell criticism; Pfizer gains 3:47 p.m. April 28, 2014 - Sue Chang
European shares up; AstraZeneca surges on M&A prospect 12:16 p.m. April 28, 2014 - Carla Mozee
Health-care market rises on Merger Monday deals 11:52 a.m. April 28, 2014 - Russ Britt
Mylan shares slump 8.9% after Meda rejects new bid 8:01 a.m. April 28, 2014 - Silvia Ascarelli
Meda rejects sweetened merger bid from Mylan 2:35 a.m. April 28, 2014 - MarketWatch.com
20 stocks that should see boost as investors seek stability: S&P's Stovall 1:19 p.m. April 21, 2014 - blogs.marketwatch.com
Mylan shares extend losses to slide 1.8% 9:33 a.m. April 8, 2014 - Sue Chang
U.S. stocks sell off; Nasdaq drop worst in 2 months 4:43 p.m. April 4, 2014 - Anora Mahmudova
Mylan shares gain 5.5% to lead S&P 500 9:32 a.m. April 4, 2014 - Sue Chang
Mylan eyes takeover of Swedish drug maker Meda 9:14 a.m. April 4, 2014 - Jonathan D. Rockoff
Mylan may buy Swedish pharma group Meda: WSJ 2:57 a.m. April 4, 2014 - Barbara Kollmeyer
U.S. stocks fall; Nasdaq skids 1.2% 4:41 p.m. March 24, 2014 - Anora Mahmudova
Apple gains on Comcast talk, new iPhone buzz 4:24 p.m. March 24, 2014 - Sue Chang
UPDATE: Bank Of America Reiterates On Mylan Following Abbott Transaction 7:49 a.m. Today - benzinga.com
'Fast Money' Recap: Will Apple's Next Phone Be Delayed? 5:00 a.m. Today - TheStreet.com
Race to Cut Taxes Fuels Urge to Merge 7:37 p.m. July 14, 2014 - The Wall Street Journal Interactive Edition
U.S. Stands to Lose Billions From Corporate-Tax Inversions 5:32 p.m. July 14, 2014 - The Wall Street Journal Interactive Edition
Mylan, AbbVie News Shows Tax Inversion Boom Continues 4:30 p.m. July 14, 2014 - Investors Business Daily
Stock Market Today: Dow Surges Above 17,000 as Citigroup Tops Street 4:14 p.m. July 14, 2014 - TheStreet.com
European Companies Fear U.S. 'Inversion' Takeovers 2:33 p.m. July 14, 2014 - The Wall Street Journal Interactive Edition
AbbVie, Shire Near $54 Billion Deal 2:13 p.m. July 14, 2014 - The Wall Street Journal Interactive Edition
Why Pharma Is Flocking to Inversions 1:53 p.m. July 14, 2014 - The Wall Street Journal Interactive Edition
Stock Market Today: Dow Above 17,000 as Citigroup Reaches $7B MBS Settlement 12:24 p.m. July 14, 2014 - TheStreet.com
Mylan Gets Abbott Generics Business in $5.3B Deal 11:02 a.m. July 14, 2014 - TheStreet.com
Mylan Buying Abbott Generics Unit, Moving Abroad 10:27 a.m. July 14, 2014 - Investors Business Daily
Abbott, Mylan Join Forces to Dodge U.S. Taxes 10:03 a.m. July 14, 2014 - 247WallSt.com
Abbott to Sell Generics Assets to Mylan for $5.3 Billion 10:00 a.m. July 14, 2014 - The Wall Street Journal Interactive Edition
Biggest Movers in Healthcare Stocks Now – MYGN MYL QCOR CNC 9:30 a.m. July 14, 2014 - InvestorPlace.com
Why Abbott Laboratories (ABT) Stock Is Up This Morning 8:48 a.m. July 14, 2014 - TheStreet.com
Trade-Ideas: Mylan (MYL) Is Today's Pre-Market Mover With Heavy Volume Stock 8:27 a.m. July 14, 2014 - TheStreet.com
Mylan buys Abbott drug assets 7:03 a.m. July 14, 2014 - Seeking Alpha
Generic Drug Stocks Soar – Your Best Healthcare Plays are TEVA and MYL 4:53 a.m. July 14, 2014 - InvestorPlace.com
Mylan set to buy Abbott drug assets 7:48 p.m. July 11, 2014 - Seeking Alpha
Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 6:30 a.m. July 14, 2014 - PR Newswire - PRF
Drug Application Submission, Merger Agreement, Launch of Newly Approved Drug, and Acquisition - Analyst Notes on Actavis, Salix, Mylan, Zoetis and Hospira 5:10 a.m. July 14, 2014 - PR Newswire - PRF
Mylan Launches Generic Micardis® Tablets 7:30 a.m. July 8, 2014 - PR Newswire - PRF
Mylan Schedules Second Quarter 2014 Financial Results Conference Call and Live Webcast for Aug. 7, 2014 1:02 p.m. July 1, 2014 - PR Newswire - PRF
Stocks Coverage on the Pharma Industry -- Research on Zoetis, Mylan, AVANIR Pharma, and Actavis 6:50 a.m. July 1, 2014 - PR Newswire - PRF
Patent Case Settlements, FDA Rulings, Upcoming Investor Day, Product Launching, and Closing of Offering - Analyst Notes on Teva, AstraZeneca, Salix, Mylan and GW 5:10 a.m. June 30, 2014 - PR Newswire - PRF
Mylan Launches Generic Actonel® Tablets, 150 mg 11:49 a.m. June 11, 2014 - PR Newswire - PRF
Critical Alerts For eBay, JA Solar, Mylan Laboratories, Future Fuel, and 51Job Technology Released By InvestorsObserver 9:31 a.m. June 11, 2014 - PR Newswire - PRF
Conference Presentations, Settlement and License Agreement, New Leadership, and Start of Phase III Study - Analyst Notes on Alexion, Mylan, Novartis, GSK and Intercept 5:50 a.m. June 11, 2014 - PR Newswire - PRF
Mylan Launches Generic Paraplatin® Injection 7:30 a.m. June 9, 2014 - PR Newswire - PRF
Mylan to Present at the Goldman Sachs 35th Annual Global HealthCare Conference 8:45 a.m. June 5, 2014 - PR Newswire - PRF
Pharma Stocks under Review -- Research on Mylan, Sanofi, Impax Laboratories, and Dr. Reddy's Laboratories 7:30 a.m. June 3, 2014 - PR Newswire - PRF
Upcoming Shareholders Meeting, Multi-Choice Medical Plans, FDA Approvals, and Investor Conference Schedules - Analyst Notes on Biogen Idec, UnitedHealth Group, Amgen, WellPoint and Mylan 7:00 a.m. June 3, 2014 - PR Newswire - PRF
Pro Football Player Adrian Peterson is Calling on Americans to be Ready2Go™ and Learn How to be Aware and Prepared for Anaphylaxis 7:30 a.m. June 2, 2014 - PR Newswire - PRF
Mylan Settles Patent Litigation Related to Celebrex® Capsules 7:00 a.m. June 2, 2014 - PR Newswire - PRF
Mylan Believes Court Erred in its Ruling Regarding Generic Celebrex® 12:43 p.m. May 30, 2014 - PR Newswire - PRF
Mylan Launches Generic Malarone® Tablets 7:30 a.m. May 29, 2014 - PR Newswire - PRF
Mylan to Present at the INVEST Pennsylvania Equity Conference 10:19 a.m. May 28, 2014 - PR Newswire - PRF
Secondary Offering, Appointments, and Clinical Developments - Analyst Notes on HCA, Biogen Idec, WellPoint, AbbVie and Mylan 7:00 a.m. May 23, 2014 - PR Newswire - PRF
Company Updates, Takeover Offers, Stock Price Movements, and FDA Approvals - Analyst Notes on Chubb, Valeant, AstraZeneca, Mylan and Perrigo 7:00 a.m. May 20, 2014 - PR Newswire - PRF
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)